Exclusion of the genes CDKN2 and PTEN as causative gene defects in Li–Fraumeni syndrome

por Burt, E C, McGown, G, Thorncroft, M, James, L A, Birch, J M, Varley, J M
Publicado 1999

Allelic imbalance of chromosome 6q in ovarian tumours.

por Orphanos, V., McGown, G., Hey, Y., Thorncroft, M., Santibanez-Koref, M., Russell, S. E., Hickey, I., Atkinson, R. J., Boyle, J. M.
Publicado 1995

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.

por Varley, J. M., McGown, G., Thorncroft, M., White, G. R., Tricker, K. J., Kelsey, A. M., Birch, J. M., Evans, D. G.
Publicado 1998

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

por Khan, O A, Gore, M, Lorigan, P, Stone, J, Greystoke, A, Burke, W, Carmichael, J, Watson, A J, McGown, G, Thorncroft, M, Margison, G P, Califano, R, Larkin, J, Wellman, S, Middleton, M R
Publicado 2011

O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib

por Watson, A J, Middleton, M R, McGown, G, Thorncroft, M, Ranson, M, Hersey, P, McArthur, G, Davis, I D, Thomson, D, Beith, J, Haydon, A, Kefford, R, Lorigan, P, Mortimer, P, Sabharwal, A, Hayward, O, Margison, G P
Publicado 2009